Serum Institute’s HPV vaccine Cervavac receives WHO prequalification
Inclusion on the WHO list allows Cervavac to be procured by U.N. agencies. The vaccine targets four HPV types and is indicated for girls and boys aged 9 through 26 years
More news in Industry
UCIL bets on greenfield mines, copper residue to double uranium output by 2036
Zydus launches in U.S. MSN Labs generic of Bayer’s PAH drug